Filter
544
Text search:
variants
Featured
Recommendations
80
New Publications
52
Language
Document type
Guidelines
131
No document type
131
Studies & Reports
115
Fact sheets
56
Strategic & Response Plan
37
Manuals
30
Videos
14
Situation Updates
9
Training Material
7
Resource Platforms
7
Infographics
4
Brochures
3
Countries / Regions
Global
29
Africa
24
Latin America and the Carribbean
18
India
15
Brazil
14
Western and Central Europe
11
Germany
10
Russia
10
Kenya
8
Syria
6
South Africa
6
East and Southern Africa
6
West and Central Africa
6
Middle East and North Africa
6
Nigeria
5
Ethiopia
5
Niger
5
Congo, Democratic Republic of
4
South Sudan
4
Malawi
4
Mozambique
4
Colombia
4
Eastern Europe
4
Senegal
3
Cameroon
3
Haiti
3
Lebanon
3
Peru
3
Bolivia
3
Myanmar / Burma
3
Chile
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Spain
3
Burkina Faso
2
Liberia
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Ghana
2
Uganda
2
Philippines
2
Turkey
2
Chad
2
Rwanda
2
Bangladesh
2
Sudan
2
Argentina
2
Ukraine
2
Nicaragua
2
Yemen
2
Kazakhstan
2
France
2
Tunisia
2
Guinea
1
Sierra Leone
1
Saudi Arabia
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
China
1
Indonesia
1
Mauritania
1
Benin
1
Central African Republic
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Western Pacific Region
1
Palestine
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Tajikistan
1
Qatar
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Gabon
1
Jamaica
1
United Kingdom
1
Portugal
1
Belarus
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
143
Clinical Guidelines
41
Public Health
30
Key Resources
15
Pharmacy & Technologies
13
Women & Child Health
9
Capacity Building
5
Toolboxes
COVID-19
261
Mental Health
34
HIV
21
Rapid Response
17
NTDs
17
Planetary Health
16
TB
15
AMR
15
NCDs
11
Global Health Education
9
Ebola
7
Conflict
7
Health Financing Toolbox
7
Caregiver
5
Refugee
4
Specific Hazards
4
Pharmacy
4
Cholera
3
Disability
2
Polio
2
Natural Hazards
2
Zika
1
In 2021 ACT-Accelerator will intensify its drive for equity and scale in the delivery of essential COVID-19 tools, while managing emerging viral risks. To address these major shifts and maintain momentum, ACT-Accelerator has defined four strategic priorities for 2021: Rapidly scale up the delivery o
...
Dengue is the fastest spreading, mosquito-borne viral infectious disease worldwide, with remarkable morbidity and mortality. In the past decades, profound contributions have been made towards understanding its epidemiology, including disease burden and distributions, risk factors, and control and pr
...
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect
...
New funding requirements: CHF 2.8 billion IFRC-wide of which CHF 670 million is channelled through the IFRC Emergency Appeal in support of National Societies
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
Biweekly situation reports
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr
...
Nature | Vol 600 | 2 December 2021 |
The content of the tool has been updated to reflect new WHO technical guidance and new evidence on both COVID-19 pandemic and mass gatherings, as well as feedback from end-users. This revision of the risk assessment tool was developed and reviewed by the WHO Mass Gathering Technical Expert Group wit
...
A new version is published in 2014
Poster, 4 Janaury 2022
Vaccines explained
recommended
WHO's 'Vaccine Explained' series features illustrated articles on vaccine development and distribution. Learn more about vaccines from the earliest of research stages to their rollout in countries.
Availble in different languages
Updated 25 January 2021
28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients.
COVID 19 Vaccine Perceptions: A 15 country study
recommended
Initial public health responses to control the pandemic focused on promoting protective behaviors among the general population, including frequent hand washing, physical distancing and the use of face masks in public spaces However, many saw these only as interim measures to reduce the spread of the
...
Nat Med (2021). https://doi.org/10.1038/s41591-021-01381-y
